Lineage, Inc.: Piper Sandler raises target price to $37 from $36
LINE•Piper Sandler raised its target price for Lineage, Inc. to $37 from $36.
Related News
Spyre Therapeutics target price raised to $141 from $123
SYRE•
Alithya net loss for three months ended Sept. 30, 2026 narrows 19% to CAD 25.02 million
ALYA•
Streamex reports GLDY gold backing of at least 100% in April-September reserve examinations
STEX•
Vir Biotechnology tumbles on $150 million stock sale
VIR•
Kanzhun plans third-quarter earnings conference call
BZ•